Patient P-01487
Synthetic patientNBL-101 · Day 92 · 35–44 · F · baseline S03Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Declining
Discontinuation risk
14%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S03
- Day 10 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 10.
Primary contributors, last 14 days
- Inflammatory activity-7
- Treatment adherence-6
- GI instability-4
- Nutritional resilience-4
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion16.1/100
improving · -1.8 vs previous 14 d
Toxicity
Blood19.9/100
stable · +0.1 vs previous 14 d
Sleep quality
Wearable36.1/100
improving · +1.8 vs previous 14 d
Energy level
Daily log5.4/10
stable · +0.1 vs previous 14 d
Stress level
Daily log4.2/10
stable · -0.2 vs previous 14 d
Steps
Wearable2,814
worsening · -344 vs previous 14 d
Adherence
Companion87.7 %
stable · -1.5 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 74 from the failing basin, 30 from restoration.
Good elements to keep
- Daily walks resumedperturbation · steering +3.3
Main detractors to watch
- Low butyrate capacityhidden · steering -17.5
- Dietary fat loadperturbation · steering -8
- Low microbial diversityhidden · steering -7.7
- Enterobacteriaceae elevatedhidden · steering -7.4
- Dietary fat loaddetractor · GI +4.9 next day
- Alcoholdetractor · GI +4.8 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Dietary fat load+4.9detractor · 95%
- Alcohol+4.8detractor · 95%
- Simple carbohydrates+3.4detractor · 95%
- Spicy / capsaicin-0.8no signal · 16%
- Histamine load-0.7no signal · 15%
- Insoluble fibre+0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓60
- MicrobiomeButyrate capacity 24/100
- MicrobiomeF. prausnitzii depleted
- Mucosal barrier integrity ↓40
- MicrobiomeAkkermansia low → thinner mucus layer
- WearableSleep 5.7 h, below personal baseline
- Autonomic recovery ↑40
- Wearable2,814 steps/day
- WearableShort sleep window
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
Microbiome
Shannon diversity 2.9 · butyrate capacity 24/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 45 ms
- Sleep
- 6.4 h
- Steps
- 2,963
- Resting HR
- 71 bpm
Daily log: GI score 16, nutritional resilience 64, adherence 88.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01346 | 52% | S12 | DT-01 | improved | 52 |
| P-01752 | 48% | S20 | DT-01 | improved | 50 |
| P-01342 | 47% | S11 | DT-01 | improved | 48 |
| P-01374 | 47% | S08 | HY-01 | improved | 49 |
| P-01593 | 47% | S10 | HY-01 | improved | 56 |
| P-01861 | 47% | S12 | HY-01 | improved | 47 |
| P-01618 | 46% | S10 | GI-04 | improved | 39 |
| P-01320 | 43% | S09 | HY-01 | improved | 38 |
| P-01555 | 43% | S06 | GI-04 | improved | 56 |
| P-01385 | 42% | S06 | HY-01 | improved | 50 |
| P-01455 | 41% | S01 | GI-04 | improved | 61 |
| P-01430 | 40% | S05 | CR-01 | improved | 54 |